Novavax Reportedly Targets December For U.S. Coronavirus Vaccine Application
Source: IBD Novavax (NVAX) reportedly plans to file for U.S. approval of its coronavirus vaccine candidate in December. NVAX stock wavered on the news. Chief Executive Stanley Erck announced the company’s […]